Ustekinumab 57894-0440-03
- Manufacturer
- Janssen Biotech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 1, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA125261
Need to source Ustekinumab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab | 45 mg/.5mL |
Drug Class
Interleukin-12 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-12 Antagonist [EPC]
Selected Package
57894-0440-03Selected1 VIAL, SINGLE-USE in 1 CARTON (57894-440-03) / .5 mL in 1 VIAL, SINGLE-USE
Other packages for this product(1)
1 SYRINGE in 1 CARTON (57894-440-01) / .5 mL in 1 SYRINGE